A Phase 2 study of oral VDPHL01 in women with pattern hair loss showed rapid and consistent hair growth, with nearly 90% of participants reporting improvement at 6 months and a favorable safety profile. Topline results from a pivotal Phase 2/3 trial are expected in 1H 2027.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.